Private Equity, VC & Investor
ACF Investors vs British Business Bank
Structured technology and market comparison · 2026
Direct Feature Comparison
ACF Investors · vs · British Business BankUK-regulated early-stage investment manager and angel co-investment platform.
UK state-owned development bank supporting finance for smaller businesses.
Analyze all overlapping signals and tech stacks for ACF Investors and British Business Bank
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between ACF Investors and British Business Bank?
When comparing ACF Investors and British Business Bank, both platforms operate within the Private Equity, VC & Investor ecosystem. ACF Investors is positioned as UK-regulated early-stage investment manager and angel co-investment platform, whereas British Business Bank focuses on UK state-owned development bank supporting finance for smaller businesses. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to ACF Investors and British Business Bank?
When evaluating ACF Investors and British Business Bank, enterprise buyers also consider other platforms in Private Equity, VC & Investor. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of ACF Investors and British Business Bank compare?
ACF Investors is headquartered in GB (founded in 2011) with 10–49 employees. British Business Bank is based in GB (founded in 2014) with 501–1,000 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: ACF Investors vs British Business Bank
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
ACF Investors
Recent Signals
- ·EU-Startups (European Venture)Funding
UK InsurTech Konsileo Raises €5.9M for AI Expansion
Konsileo, a UK-based chartered commercial insurance broker, has raised €5.9 million (£5 million) in an equity round led by long-term shareholder Committed Capital, with participation from ACF Investors. Founded in 2017 by John Warburton and Peter Henderson, the company employs over 220 people and arranges more than €100.5 million (£85 million) in annual premiums. Its proprietary end-to-end platform automates administrative tasks, embeds compliance checks, and improves risk data capture, reducing process effort by half. The funding will support further platform development, integration of AI capabilities, and attraction of experienced brokers. This follows €3.2 million raised in 2018 and €9.4 million in debt and equity financing in 2024. Konsileo operates a 'Teal' organizational model with self-managed teams and focuses on organic growth.
- Konsileo raised €5.9 million (£5 million) in an equity round led by Committed Capital with participation from ACF Investors.
- Founded in 2017 by John Warburton and Peter Henderson, the company employs over 220 people and arranges more than €100.5 million (£85 million) in annual premiums.
- The funding will be used to expand the platform with AI capabilities and attract experienced brokers.
British Business Bank
Recent Signals
- ·EU-Startups (European Venture)Funding
Microbiotica lands €42M Series C for microbiome therapy
Microbiotica, a British clinical-stage biopharma company, has announced the first close of a €42 million (£36 million) Series C financing round. The round was led by British Business Bank, with participation from Tencent, IP Group, Cambridge Innovation Capital, Flerie Invest, and Seventure Partners, and included all existing Series B investors. The funds will be used to advance MB310, its precision microbiome therapy for ulcerative colitis, into Phase 2 clinical development, following positive Phase 1b results. Microbiotica's platform, spun out of the Wellcome Sanger Institute, identifies bacterial strains linked to favorable clinical outcomes. The company also partners with MSD, Cancer Research UK, and Genentech. This funding round is part of a broader trend of European biotech investments in microbiome and related therapies.
- Microbiotica announced a €42 million Series C financing round.
- The financing was led by British Business Bank with participation from Tencent, IP Group, Cambridge Innovation Capital, Flerie Invest, and Seventure Partners.
- The funds will support the Phase 2 clinical development of MB310 for ulcerative colitis.
- ·Tech.eu (European Tech & Deals)Venture Capital Funding
British Business Bank Invests £180M Across AI and Deeptech Funds
The British Business Bank, a state-owned investor, has announced a £180 million investment across six AI and deeptech venture capital funds. The investments include £35 million in Crane Ventures Partners' Crane III fund, £20 million in Connect Ventures' Connect V fund, £22 million in Entrepreneurs First's early-stage fund, £55 million in Intrepid Growth Partners' Fund I, £26 million in Headline's EU VIII fund, and £22 million in Evantic Fund I. This move follows a government review that increased the bank's spending power, aiming to strengthen the UK's funding landscape for AI and deeptech startups. The bank has also previously invested directly in companies like Wayve, Kraken Technologies, and PolyAI. Chief Investment Officer Leandros Kalisperas stated the strategy aims to create deeper pools of funding at all stages of growth, helping companies access greater capital domestically.
- British Business Bank invests £180M across six AI and deeptech VC funds.
- Investments include £35M in Crane Ventures Partners' Crane III, £20M in Connect Ventures' Connect V, £22M in Entrepreneurs First, £55M in Intrepid Growth Partners' Fund I, £26M in Headline's EU VIII, and £22M in Evantic Fund I.
- The bank has previously invested directly in Wayve, Kraken Technologies, and PolyAI.
- ·EU-Startups (European Venture)Funding
Nauta closes €60M first close for sixth fund
Nauta, a London-based pan-European VC, announced the first close of its sixth fund at €60 million. The British Business Bank anchored the fund with a €30 million commitment, marking its fourth consecutive participation in a Nauta fund. Other LPs include SETT, Merifin Capital, and Institut Català de Finances. The fund targets a total size between €150 million and €200 million, with a final close expected in H2 2027. Nauta invests in B2B software and DeepTech startups from pre-Seed to Series A, with a focus on high-performance computing, AI infrastructure, cybersecurity, industrial automation, digital health, and energy frontier technology. The firm has backed over 200 founders across 100 companies and generated nearly €3 billion in exit value.
- Nauta announced the first close of its sixth fund at €60 million.
- British Business Bank committed €30 million as anchor investor.
- Other LPs include SETT, Merifin Capital, and Institut Català de Finances.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners ACF Investors and British Business Bank share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks